OphthalmologyNews.net

Ophthalmology Xagena

Xagena Mappa
Medical Meeting
Ematobase.it
Mediexplorer.it

Researchers at University of California – Los Angeles ( UCLA ) have discovered that RPE65, a gene missing in infants born with the blinding disease Leber congenital amaurosis, is also a key enzyme in ...


Children who were born prematurely are more likely to have visual problems at 10 years of age than children who were born at full term. Eye and neurological problems are common in premature infants ...


A single-masked Phase I/II clinical study of the investigational drug Lucentis ( Ranibizumab ) met its primary efficacy endpoint of maintaining vision in patients with wet age-related macular degenera ...


Researchers at the University of Minnesota participated in a nationwide clinical trial that determined that many children ages seven through 17 with amblyopia ( lazy eye ) may benefit from treatments ...


Imaging data from a Phase 2 study of Pegaptanib ( Macugen ) in diabetic macular edema ( DME ) showed a reversal of capillary microaneurysms, retinal ischemia and neovascularization -- all important ...


A Phase III clinical trial of the drug Ranibizumab ( Lucentis ) met its primary efficacy endpoint of maintaining vision in patients with wet age-related macular degeneration (AMD ). Approximately ...


Corneal transplant patients who suffer from eye allergies are at a significantly higher risk of transplant failure than those without allergies. " We found that the immune system's response to co ...